EcoDrugPlus

Prostaglandin I2 Receptor

Ensembl ID : ENSEEUG00000000348
Gene Symbol: PTGIR
1 External references
188 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSEEUG00000008541
Gene Symbol: PTGS1
1 External references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSEEUG00000014083
Gene Symbol: PTGS2
1 External references
240 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSEEUG00000000047
Gene Symbol: PSMA1
1 External references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSEEUG00000007600
Gene Symbol: PSMA2
1 External references
257 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSEEUG00000000678
Gene Symbol: PSMA4
1 External references
251 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSEEUG00000008368
Gene Symbol: PSMA5
1 External references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSEEUG00000002265
Gene Symbol: PSMA7
1 External references
155 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSEEUG00000014684
Gene Symbol: PSMB2
1 External references
221 Possible Orthologues:

Proteasome 20s Subunit Beta 3

Ensembl ID : ENSEEUG00000015275
Gene Symbol: PSMB3
3 External references
250 Possible Orthologues:

Proteasome 20s Subunit Beta 6

Ensembl ID : ENSEEUG00000002083
Gene Symbol: PSMB6
1 External references
222 Possible Orthologues:

Proteasome 20s Subunit Beta 7

Ensembl ID : ENSEEUG00000005513
Gene Symbol: PSMB7
1 External references
217 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).